MIT engineers develop a way to mass manufacture nanoparticles that deliver cancer drugs directly to tumors
Peer-Reviewed Publication
MIT researchers developed a manufacturing technique that rapidly generates large quantities of nanoparticles coated with drug-delivering polymers, which hold great potential for treating cancer. The particles can be targeted directly to tumors, where they release their payload while avoiding many of the side effects of traditional chemotherapy.
A new method assesses and improves the reliability of radiologists’ diagnostic reports. The framework helps clinicians choose terms that more accurately reflect the likelihood that certain conditions are present in X-rays.
A new study published in the Journal of Vertebrate Biology by the Academy of Sciences of the Czech Republic, conducted by researchers from MARE, reveals new insights into the reproductive biology of the sheatfish, also known as the European catfish, in the Tagus River. Carried out as part of the LIFE-PREDATOR project (https://lifepredator.eu/), this study is the first to analyze the reproductive biology of the catfish populations in the Iberian Peninsula and one of the few conducted within its invasion area.
More than two-fifths of Oregon community pharmacies require a prescription to purchase syringes, even though they can be sold over the counter, creating an access barrier that could exacerbate the spread of bloodborne diseases like hepatitis C.
Early administration of the drug Fosdenopterin/rcPMP improves the chances of survival of infants with MoCD type A and promotes the development of brain functions / publication in the Journal of Inherited Metabolic Diseases
An archaeological study of human settlement during the Final Palaeolithic revealed that populations in Europe did not decrease homogenously during the last cold phase of the Ice Age. Significant variation in regional population sizes indicate differentiated reactions nested in an overall shift of settlement areas towards the east / publication in PLOS One
In a new extensive systematic review, Mass General Brigham researchers identified 17 modifiable risk factors that are shared by stroke, dementia, and late-life depression. Modifying any one of them can reduce your risk of all three conditions. The findings, which provide evidence to inform novel tools, such as the Brain Care Score, are published in the Journal of Neurology, Neurosurgery, and Psychiatry.